Emcure Pharmaceuticals Limited (NSE:EMCURE)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2012	Mar 31, 2011
Pharmaceuticals	92.04B	78.96B	66.58B	59.86B	58.55B
Total	92.04B	78.96B	66.58B	59.86B	58.55B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2012	Mar 31, 2011
India	40.27B	36.60B	32.15B	31.82B	32.05B
Europe	18.50B	14.74B	14.24B	11.87B	8.97B
North America	14.87B	12.52B	9.28B	7.29B	6.79B
Other Continents	18.40B	15.10B	10.92B	8.87B	10.74B
Total	92.04B	78.96B	66.58B	59.86B	58.55B

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error